Category: Drugs development
- AI Takes On Drug Discovery ()
By Mike May, PhD Artificial intelligence appears poised to transform many aspects of our lives, and drug discovery is no exception. By removing much of the trial and error from drug discovery, AI reveals new targets and tactics for treating diseases. “AI is an umbrella for different types of machine learning models that can be […]
- Using AI to create better, more potent medicines ()
While it can take years for the pharmaceutical industry to create medicines capable of treating or curing human disease, a new study suggests that using generative artificial intelligence could vastly accelerate the drug-development process. Today, most drug discovery is carried out by human chemists who rely on their knowledge and experience to select and synthesize […]
- Drug discovery companies are customizing ChatGPT: here’s how ()
Large language models are helping scientists to converse with artificial intelligence and even to generate potential drug targets. Much of the world has been transfixed in recent months by the appearance of text generation engines such as OpenAI’s ChatGPT, artificial intelligence (AI) algorithms capable of producing text that seems as if it were written by […]
- An opinion of ChatGPT about smart drugs ()
ChatGPT: I think the concept of “smart drug” is generally associated with nootropics, which are substances that enhance cognitive functions of the brain, rather than drugs designed to treat organ diseases. However, there are drugs intended to treat organ diseases that can be considered “smart” due to their ability to specifically target affected areas while […]
- Cryonics Patients will probably be revived by/with drug developments. ()
Cryonics Patients will probably be revived by/with drug developments. With the power of humans, AI and Quantum Technologies.
- Biotechs are applying AI and machine learning to drug development ()
Biotechs are applying AI and machine learning to drug development, potentially creating dozens of new medicines and a $50 billion market over the next decade. Here’s what that means for patients and investors. For biotechnology companies, much of the traditional process of discovering new drugs is costly guesswork. But a new wave of drug development […]